The ROE as of September 2024 (TTM) for Ventyx Biosciences, Inc. (VTYX) is -61.43%

According to Ventyx Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -61.43%. This represents a change of 295.34% compared to the average of -15.54% of the last 4 quarters.

Ventyx Biosciences, Inc. (VTYX) Historical ROE (quarterly & annually)

How has VTYX ROE performed in the past?

The mean historical ROE of Ventyx Biosciences, Inc. over the last ten years is 47.31%. The current -61.43% ROE has changed -229.84% with respect to the historical average. Over the past ten years (40 quarters), VTYX's ROE was at its highest in in the March 2021 quarter at 122.81%. The ROE was at its lowest in in the December 2023 quarter at -19.17%.

Ventyx Biosciences, Inc. (VTYX) ROE by Quarter and Year

Discovering the peaks and valleys of Ventyx Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ventyx Biosciences, Inc. (VTYX) Average ROE

How has VTYX ROE performed in the past?

The current ROE of Ventyx Biosciences, Inc. (VTYX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ventyx Biosciences, Inc. (VTYX) ROE vs. Peers

How is VTYX’s ROE compared to its peers?

Ventyx Biosciences, Inc.’s ROE is greater than Arcellx, Inc. (-12.42%), greater than Immunocore Holdings plc (-17.57%), greater than Vaxcyte, Inc. (-30.07%), greater than DICE Therapeutics, Inc. (-102.37%), greater than Nuvalent, Inc. (-28.83%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Travere Therapeutics, Inc. (-102.43%), greater than Structure Therapeutics Inc. (-20.15%), less than Replimune Group, Inc. (0%), greater than Ascendis Pharma A/S (-52.15%), less than United Therapeutics Corporation (251.76%), less than IDEAYA Biosciences, Inc. (18.82%), greater than Protagonist Therapeutics, Inc. (-20.53%), less than Verona Pharma plc (85.47%), greater than Syndax Pharmaceuticals, Inc. (-55.46%), greater than null (-57.42%),

Build a custom stock screener for Ventyx Biosciences, Inc. (VTYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ventyx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ventyx Biosciences, Inc. (VTYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ventyx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.